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Meckel–Gruber syndrome (MKS) is a lethal autosomal recessive congenital anomaly 
syndrome caused by mutations in genes encoding proteins that are structural or func-
tional components of the primary cilium. Conditions that are caused by mutations in 
ciliary genes are collectively termed the ciliopathies, and MKS represents the most 
severe condition in this group of disorders. The primary cilium is a microtubule-based 
organelle, projecting from the apical surface of vertebrate cells. It acts as an “antenna” 
that receives and transduces chemosensory and mechanosensory signals, but also 
regulates diverse signaling pathways, such as Wnt and Shh, that have important roles 
during embryonic development. Most MKS proteins localize to a distinct ciliary com-
partment called the transition zone (TZ) that regulates the trafficking of cargo proteins 
or lipids. In this review, we provide an up-to-date summary of MKS clinical features, 
molecular genetics, and clinical diagnosis. MKS has a highly variable phenotype, 
extreme genetic heterogeneity, and displays allelism with other related ciliopathies 
such as Joubert syndrome, presenting significant challenges to diagnosis. Recent 
advances in genetic technology, with the widespread use of multi-gene panels for 
molecular testing, have significantly improved diagnosis, genetic counseling, and the 
clinical management of MKS families. These include the description of some limited 
genotype–phenotype correlations. We discuss recent insights into the molecular basis 
of disease in MKS, since the functions of some of the relevant ciliary proteins have now 
been determined. A common molecular etiology appears to be disruption of ciliary TZ 
structure and function, affecting essential developmental signaling and the regulation of 
secondary messengers.
Keywords: Meckel–Gruber syndrome, renal cystic dysplasia, oligohydramnios, primary cilium, transition zone, 
Shh signaling
CLiniCAL FeATUReS
Meckel–Gruber syndrome (MKS, OMIM number #249000), sometimes simply termed Meckel 
syndrome, was first described by Johann Friedrich Meckel in 1822. Meckel noted two siblings 
who died soon after birth with typical features that included occipital encephalocele, polycystic 
kidneys, and polydactyly (1). Gruber described the same condition later, naming it dysencephalia 
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splanchnocystica (2). In the 1960s, the condition was further 
delineated by Opitz and Howe (3) with subsequent refinement of 
the diagnostic criteria (4–7).
Meckel–Gruber syndrome is a lethal developmental syn-
drome characterized by posterior fossa abnormalities (most 
frequently occipital encephalocele) (Figures  1A,B), bilateral 
enlarged cystic kidneys (Figures 1C–E), and hepatic develop-
mental defects that include ductal plate malformation associ-
ated with hepatic fibrosis and cysts (Figure 1F) (8). A common 
additional feature is postaxial polydactyly, usually affecting both 
hands and feet (Figure 1A), which is seen in 70–80% of cases 
(5–7, 9). Other occasional features, seen in 25–40% of fetuses 
include bowing and shortening of the long bones, abnormalities 
of the male genitalia, microcephaly or anencephaly, cleft lip and 
palate, and other craniofacial abnormalities, congenital heart 
defects, and pulmonary hypoplasia (5, 6, 8, 9). Rare features 
(seen in less than 20% of cases) include cystic dysplasia of the 
lungs or thyroid, retinal colobomata, and situs defects (8–14). 
Central nervous system (CNS) defects are considered to be 
obligate features of MKS but appear to have a variable presenta-
tion, varying between total craniorachischisis, partial defects of 
the corpus callosum, Dandy–Walker malformation, and most 
frequently occipital encephalocele (15).
Renal cystic dysplasia is the most characteristic feature of 
MKS, but differs from those typical of polycystic kidney disease. 
The degree of cyst formation varies between individuals with 
MKS, but the kidneys will often be grossly enlarged, causing mas-
sive swelling of the abdomen (Figures 1A,D). Large, fluid-filled 
cysts are visible by eye in most affected individuals. However, in 
other small cysts, cystic changes of the proximal tubules and the 
absence of normal renal parenchyma are visible by microscopic 
investigation (Figure 1E). Cysts develop first in the glomeruli 
in the cortex, and cystogenesis progresses along the tubules 
and collecting ducts in the medulla. Abnormal fetal renal func-
tion is a frequent cause of oligohydramnios or anhydramnios, 
a common complication of an MKS pregnancy (7, 9). Potter’s 
sequence is frequent (pulmonary hypoplasia, growth restriction, 
club feet, and contractures) with a distinctive facies (comprising 
slanting forehead, flattened nose, and low-set ears) (Figure 1A), 
and is secondary to oligohydramnios or anhydramnios dur-
ing pregnancy. In addition to cystic kidney dysplasia, hepatic 
involvement is an obligate feature of MKS (6). The typical 
histology shows bile duct proliferation and dilation (Figure 1F), 
associated with excess collagenous connective tissues (8), which 
are thought to arise from the incomplete development of the 
hepatic biliary system (16, 17).
GeneTiCS AnD ALLeLiSM
Autosomal recessive (AR) inheritance for MKS is confirmed 
by equal occurrence in males and females, concordance in 
monozygotic twins, examples of affected siblings, and, in some 
cases, parental consanguinity. If the condition has occurred 
in previous pregnancies then the recurrence risk is 25%. The 
worldwide incidence of MKS has been estimated at 1 in 135,000 
live births (18), but higher incidences of MKS are observed 
in endogamous populations, such as Gujarati Indians (19), 
Tatars (20), Hutterites (21), and in Finland (22) where 1 in 
every 9,000 live births is affected. MKS incidence is also higher 
in consanguineous populations, such as Kuwaiti Bedouin 
tribes (1 in 3,530 births) (23) and populations in Saudi Arabia 
(1 in 3,500 births) (24).
Meckel–Gruber syndrome has extreme genetic heterogene-
ity and displays allelism with other ciliopathies such as Joubert 
syndrome (JBTS), COACH syndrome (cerebellar vermis hypo/
aplasia, oligophrenia, congenital ataxia, ocular coloboma, and 
hepatic fibrosis), oro-facio-digital syndrome (OFD), nephro-
nophthisis (NPHP), and Bardet–Biedl syndrome (BBS). To date, 
mutations in 14 genes (including TXNDC15) are identified as 
causative for MKS (Table 1). Mutations in a further three genes, 
specifically C5orf42 (25), CSPP1 (26), and CEP55 (27), are 
implicated on the basis of pathogenic private mutations in 
individual families with either MKS or MKS-like phenotypes 
(Table  1). Two other genes, comprising SEC8 (also known as 
EXOC4) (25) and EXOC3L2 (28), have private mutations as a 
cause of probable MKS phenotypes. In total, mutations in these 
genes appear to explain only 50–60% of MKS cases (28, 29).
Mutations in TMEM67, RPGRIP1L, and TMEM216 can 
cause both JBTS and MKS, demonstrating allelism between 
these conditions (31, 35, 36, 46) (Table 1). Biallelic mutations in 
the known MKS genes can also cause other related and allelic 
ciliopathies. Most notably, mutations in CEP290 (MKS4) can 
also occur in patients with NPHP (47), Senior-Løken syndrome 
(SLSN), JBTS (34), BBS (48), COACH syndrome (49), and Leber 
congenital amaurosis (50). The variable expressivity of the MKS 
phenotype can complicate the diagnosis of the condition, since 
this can extend to intra-familial variation for individuals that 
carry the same pathogenic mutation within families (31), even 
between monozygotic twins (7). The effect of non-Mendelian 
inheritance modes or the influence of genetic modifier alleles 
has frequently been proposed to explain some of this variation. 
However, in a cohort of JBTS patients who shared causal alleles 
but had discordant phenotypic features, digenic, or oligogenic 
inheritance modes were largely excluded as disease mechanisms 
(51). A second recent study suggests that ciliopathy phenotypes, 
including those for MKS, are allele-specific and that stochastic 
effects have a more important role on phenotypic variability than 
modifier alleles (28).
GenOTYPe–PHenOTYPe CORReLATiOnS
In recent years, the identification of pathogenic alleles specific 
to MKS, limited genotype–phenotype correlations and founder 
mutations for particular ethnic groups (Table 1) have facilitated 
the rapid and accurate genetic diagnosis of this condition. 
Mutations in MKS1 cause ca. 7% of all MKS cases and ca. 70% 
cases in Finland. Most Finnish MKS patients share the common 
“Finn major” mutation (MKS1 IVS15-7_35del; Table 1), which 
is thought to have arisen in a founder of the Finnish population 
(52). Skeletal involvement including shortening and bowing 
of the long bones, polydactyly, and occipital encephalocele are 
frequently seen in patients with the Finn major mutation (18). 
More generally, MKS1 mutations are associated with higher rates 
of polydactyly and occipital encephalocele, bone dysplasia, cleft 
FiGURe 1 | Continued
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palate, and situs defects (52). All MKS1 mutations reported in 
MKS patients are null mutations, but a hypomorphic mutation 
has been reported in an individual with BBS (48), and recently in 
individuals with JBTS (53, 54).
TMEM67 mutations are estimated to cause 16% of MKS cases 
(55), making them the most frequent cause of MKS. Both CNS 
malformations and polydactyly are less frequent in TMEM67-
mutated individuals than those with MKS1 mutations (56). 
TAbLe 1 | Summary of known MKS loci and identified genes.
Locus Gene entrez gene iD Aliases Location Founder mutation(s) Reference
MKS1 MKS1 54903 MKS, BBS13, JBTS28 17q22 Finnish c.1408-35_1408-7del29 (30)
MKS2 TMEM216 51259 JBTS2, CORS2 11q12.2 Ashkenazi c.218G > T (p.R73L) (31, 32)
MKS3 TMEM67 91147 JBTS6, NPHP11, MECKELIN 8q22.1 Pakistani c.1575 + 1G > A (33)
MKS4 CEP290 80184 KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, 
BBS14, NPHP6
12q21.32 (34)
MKS5 RPGRIP1L 23322 KIAA1005, JBTS7, CORS3, FTM, NPHP8 16q12.2 European c.1843A > C (p.T625P) (35, 36)
MKS6 CC2D2A 57545 KIAA1345, JBTS9 4p15.32 Finnish c.1762C > T (p.?) (37)
MKS7 NPHP3 27031 SLSN3, NPHP3, NPH3, RHPD1 3q22.1 (38)
MKS8 TCTN2 79867 C12orf38, TECT2, JBTS24 12q24.31 (39)
MKS9 B9D1 27077 MKSR1, JBTS27 17p11.2 (40)
MKS10 B9D2 80776 MKSR2 19q13.2 (41)
MKS11 TMEM231 79583 JBTS20 16q23.1 (42)
NA C5orf42 65250 OFD6, JBTS17 5p13.2 (25)
NA CSPP1 79848 JBTS21, CSPP 8q13.1-q13.2 (26)
MKS12 KIF14 9928 KIAA0042 1q32.1 (43)
MKS13 TMEM107 84314 JBTS29, PRO1268 17p13.1 (44, 45)
NA TXNDC15 79770 C5orf14, UNQ335 5q31.1 (28)
NA CEP55 55165 CT111, URCC6, C10orf3 10q23.33 (27)
Assigned locus names are listed, with unassigned ones indicated by NA. Alias names of genes or loci summarize the alternative gene symbols, names, and any reported allelism 
with other ciliopathies (indicated by the gene symbol or locus name). Any reported founder mutations in specific populations are also listed, in addition to the original gene discovery 
paper or papers.
CORS, cerebellar–ocular–renal syndrome; JBTS, Joubert syndrome; MKS, Meckel–Gruber syndrome; NPHP, nephronophthisis; OFD, oro-facio-digital syndrome; SLSN, Senior-
Løken syndrome.
FiGURe 1 | Continued   
Clinical features of Meckel–Gruber syndrome (MKS) and schematic of primary cilia structure. (A) Typical external features for a fetus with MKS at gestation age 
16/40, showing typical clinical features comprising occipital encephalocele, massive flank masses due to bilateral renal cystic dysplasia, postaxial hexadactyly of all 
limbs, and a typical Potter’s sequence facies with a slanting forehead and flattened nose. (b,C) Ultrasound findings at 14+/40 weeks of gestation for MKS showing 
(b) encephalocele (arrowheads), and (C) large cystic kidneys (arrowhead). (D) Massive swelling of the abdomen of a fetus at gestation age 18+/40 with MKS due to 
grossly enlarged, cystic kidneys. (e) Hematoxylin-eosin staining of MKS fetal kidney at gestation age 18+/40 showing cystic dysplasia, comprising large, fluid-filled 
cysts, small cysts, and cystic swelling of the proximal tubules and glomeruli, with the absence of normal renal parenchyma. (F) Immunohistochemical staining of 
MKS fetal liver at gestation age 18+/40 for cytokeratin-19, showing the retention of embryonic bile duct structures (the ductal plate malformation) without the 
formation of patent bile ducts (arrowhead). PV, hepatic portal vein. (G) Left: simplified schematic of cilium ultrastructure (individual components are not to scale).  
For the purposes of clarity, the ciliary axoneme is represented by two doublets of microtubules (the A- and B-tubules; gray rods), and the nine-fold symmetry in the 
structure is indicated by dark gray ovals in the mother centriole. The axoneme is bound by ciliary membrane (red/brown line and shading). The ciliary transition zone 
(TZ) is characterized by Y-shaped links (pink) that mediate interactions with the ciliary membrane. The permeability barrier called the “ciliary gate” is indicated by the 
dashed pink ovals and pink shading, and is thought to consist of transition fibers and TZ proteins. Ciliary cargo proteins (purple) are trafficking by vesicular transport 
mediated by coordinated interactions between the Rab family of small GTPases (RAB11 and RAB8; R8), the RAB8 activator protein Rabin8 (R), and the exocyst 
protein complex (Ex) at the ciliary base. The exocyst tethers vesicles to the periciliary membrane, facilitating transport through the ciliary gate (green arrow), followed 
by transport within the cilium mediated by intraflagellar transport (IFT; dashed black arrows). Right: schematic of a TZ model, showing the possible location of TZ 
proteins mutated in MKS and related ciliopathies (pink ovals) forming the “MKS-JBTS module,” RPGRIP1L (blue oval) which is thought to be a component of a ciliary 
assembly module, and a third functional module (brown) that is associated with nephronophthisis (NPHP) proteins. The selective transport of cargo transmembrane 
proteins (lilac or purple) is indicated by arrows. The proteins include G-protein-coupled receptors (GPCRs), and effectors of the Shh signaling pathway (Smoothened 
and Patched). Images (A–C) are used by kind permission of Dr. Riitta Salonen (Rinnekoti Foundation, Helsinki, Finland) from the Robert J. Gorlin Slide Collection. 
JBTS, Joubert syndrome.
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TMEM67 mutations also account for 57–83% (49, 55, 57) of the 
JBTS variant phenotype of COACH syndrome, demonstrating a 
strong genotype–phenotype correlation of TMEM67 mutations 
with hepatic developmental defects or coloboma (49, 58). This 
correlation indicates that JBTS patients with hepatic involve-
ment are prioritized for TMEM67 mutation testing (57). Other 
genotype–phenotype correlations for MKS or JBTS have been 
identified by mutation type, or by the location of missense muta-
tions within protein domains. For example, CC2D2A missense 
mutations are associated with JBTS whereas MKS is caused by 
null alleles (59). Missense mutations in exons 8–15 of TMEM67, 
particularly in combination with a second truncating mutation, 
are also associated with MKS (29, 55). Homozygous truncat-
ing mutations in RPGRIP1L are associated with MKS, whereas 
missense mutations (either in the homozygous state or compound 
heterozygous with a truncating mutation) are prevalent for JBTS 
patients. MKS phenotypes associated with RPGRIP1L mutations 
tend to be severe, including anencephaly and shortening and 
bowing of the long bones, in addition to the classic triad (36).
DiAGnOSiS, CLiniCAL MAnAGeMenT, 
AnD GeneTiC COUnSeLinG
Meckel–Gruber syndrome is lethal in utero or immediately after 
birth, often due to pulmonary hypoplasia, although an unusual 
survivor has been described aged 28  months (60). MKS has 
a broad, multi-organ phenotype with considerable variation, 
but it is generally diagnosed by the presence of cystic kidney 
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dysplasia (Figure 1C), in addition to at least one other hallmark 
feature of the disease. These comprise occipital encephalocele 
(Figure 1B), polydactyly (Figure 1A), or hepatic developmental 
abnormalities such as the ductal plate malformation (Figure 1F) 
(6, 7). The presence of abnormal intrahepatic bile ducts and 
cystic kidneys has been proposed to be invariant features 
of MKS and appears to be pathognomonic for the condition 
(6, 17). Salonen (6) has proposed that the minimal diagnostic 
criteria for MKS are CNS malformation, bilateral multicystic 
kidneys, and hepatic fibrotic changes.
Transabdominal ultrasonography, performed at 10–14 weeks 
gestation, has been shown to successfully detect several of the 
fetal anomalies associated with MKS, including polycystic 
kidneys (from 9 weeks gestation), occipital encephalocele (from 
13 weeks), and polydactyly (from 11 weeks), in both high-risk 
and low-risk pregnancies (Figure  1B) (60–64). Visualization 
can be compromised by oligohydramnios (65), but this is less 
problematic when performed in the first trimester of pregnancy 
(62). Further investigation of anomalies is possible by transvagi-
nal scanning. Enlargement of the fetal trunk can give an early 
indication of multicystic renal dysplasia (66), in addition to unu-
sually heterogeneous corticomedullary differentiation, reduced 
echogenicity of the medulla, increased echogenicity of the cor-
tex, and the visualization of small medullary cysts (Figure 1C) 
(67). The fetal bladder can also be visualized by ultrasonography 
from 11 weeks, and the absence of a visible fetal bladder is often 
indicative of renal dysfunction.
Fetal MRI is an alternative if ultrasonography findings are 
inconclusive or lack of amniotic fluid prevents clear imaging. 
MRI offers better soft-tissue resolution than ultrasonography, 
and can provide clearer images of intracranial structures to 
enable an accurate diagnosis of CNS malformations, but is 
rarely performed before 18 weeks gestation. Fetal movement and 
maternal aortic pulsation do not preclude a successful diagnosis 
of MKS using MRI (68), since imaging artifacts caused by fetal 
movement can be minimized by a fetal neuromuscular blockade 
(69) or general anesthesia of the mother. Transabdominal or 
vaginal endoscopy in the first trimester of pregnancy allows 
diagnosis of MKS by visualization of the surface anatomy of the 
embryo. Fetoscopy enables the direct observation of polydactyly 
and occipital encephalocele from 11 weeks gestational age (70). 
Prenatal diagnosis is also possible by using a combination of these 
imaging techniques, α-fetoprotein testing of amniotic fluid, and 
DNA testing of fetus and parents. For example, elevated levels of 
maternal α-fetoprotein during antenatal screening may be associ-
ated with MKS (61).
Definitive diagnosis is often possible by using DNA testing 
to screen for mutations in the known MKS genes. Molecular 
diagnostic strategies include mutation screening of individual 
genes or targeted clonal sequencing of multi-gene panels. Single 
gene testing has low diagnostic sensitivity because of the absence 
of clear genotype–phenotype correlations for MKS. However, 
once a pathogenic variant in a family has been identified, then 
prenatal genetic diagnosis by chorionic villus sampling can be 
prioritized for at-risk pregnancies. Multi-gene panels can include 
MKS genes, and other ciliopathy genes of interest, that can be 
tested by sequence analysis and deletion/duplication analysis 
(71). However, their diagnostic sensitivity can vary between 
laboratories because panels can include genes that are unrelated 
to MKS. Referring clinicians should therefore decide which 
multi-gene panel has the best balance of sensitivity and afford-
ability. If testing by a multi-gene panel does not confirm a clinical 
diagnosis of MKS, then more comprehensive testing by either 
whole-exome sequencing or whole-genome sequencing (WES or 
WGS) should be considered for obligate carriers. However, these 
tests may support or suggest unexpected diagnoses, in view of 
the broad range of possible differential diagnoses for MKS. These 
are extensive and include Smith–Lemli–Opitz syndrome, trisomy 
13, hydrolethalus syndrome, and other related ciliopathies that 
include AR polycystic kidney disease, BBS, JBTS, and OFD. In 
particular, the prenatal features of BBS (polydactyly, renal defects, 
hepatic anomalies, genital hypoplasia, and heart malformations) 
can lead to a misdiagnosis of MKS (72). The extensive range of 
differential diagnoses and the broad allelism between different 
ciliopathies highlights the clinical need for accurate molecular 
diagnosis and the refinement of genotype–phenotype correla-
tions (71, 73).
Since MKS has an AR inheritance pattern, couples with a 
previously affected child should have the opportunity for genetic 
counseling with a medical professional in order to discuss the 
nature, inheritance, and implications of an MKS diagnosis. The 
possibility of prenatal testing needs appropriate counseling of 
parents if it is being considered for the purpose of pregnancy 
termination in addition to early diagnosis. Individual opinions 
regarding prenatal testing and pregnancy termination may 
depend on a number of factors such as religious and cultural 
beliefs, and previous experiences of the medical condition 
(74, 75). An accurate perception of their genetic risk, a clear 
impact of genetic disorder and previous experience of having 
an affected child can help parents to make an informed decision 
(76). It is therefore appropriate to discuss these issues at an early 
stage to ensure that families can make informed medical and 
personal decisions.
With consanguineous MKS families, geneticists will encour-
age disclosure to at-risk relatives. The fact that these individuals 
often do not seek carrier testing suggests that many families are 
not sharing this information. In families with an AR disorder 
who practice consanguinity, the concern that their children’s car-
rier status would affect their marriage prospects can contribute 
to non-disclosure of this important information to their wider 
family (76–78). Furthermore, there is a widespread assumption 
among healthcare professionals that Muslim patients will not 
accept termination of pregnancy (79). However, under a fatwā 
(an Islamic legal pronouncement), termination of pregnancy 
is permitted before “ensoulment” at 120 days in cases of severe 
disability such as MKS, or where there is a risk to the mother’s 
life (75, 80), but knowledge of the fatwā is limited among Muslim 
populations (75, 81).
inSiGHTS inTO MOLeCULAR 
PATHOMeCHAniSMS
The primary cilium is a microtubule-based organelle, pro-
jecting from the apical surface of vertebrate cells. It acts as 
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an “antenna” that receives and transduces chemosensory 
and mechanosensory signals (Figure  1G). Primary cilia are 
thought to be hubs of developmental signaling that regulate 
diverse pathways such as Wnt and Shh that have essential roles 
during embryonic development. In particular, mutations MKS 
genes cause defective Shh signaling in several mouse models of 
ciliopathies (82–85). Primary cilia have a complex architecture 
that defines the compartmentalization of ciliary proteins, and 
many genes that are mutated in MKS encode proteins that 
localize to the ciliary TZ. This is a distinct molecular compart-
ment located at proximal regions of cilia (86, 87) that has been 
defined by genetic and biochemical approaches to consist of 
protein complexes forming the so-called “MKS-JBTS module” 
(Figure 1G). The TZ connects the microtubules of the ciliary 
axoneme to the plasma and ciliary membranes, and it has been 
suggested to both limit and assist the regulated trafficking of 
cargo proteins and lipids into and out of the cilium (88). The TZ 
is therefore thought to modulate the composition of essential 
ciliary compartments such as the ciliary membrane, axoneme, 
and associated proteins (88). A recent study demonstrated 
that the disruption of ciliary TZ architecture causes JBTS (89), 
but how this affects ciliary trafficking and causes the MKS or 
other ciliopathy phenotypes remains a research question of 
paramount importance.
Genetic, biochemical, and proteomic approaches have delin-
eated the networks of protein-protein interactions that underlie 
the functional “MKS-JBTS module” at the TZ, as well providing 
insights into the structural basis of selective permeability at 
this ciliary compartment (90, 91). For example, several small 
tetraspanin-like transmembrane proteins (TMEMs) that are 
mutated as a cause of MKS and other ciliopathies (TMEM216, 
TMEM231, and TMEM107) appear to localize to the specialized 
ciliary membrane at the TZ. Other transmembrane proteins at 
this compartment include the Tectonic proteins (TCTN1, 
TCTN2, and TCTN3) and the Frizzled-like receptor TMEM67. 
In turn, the TMEM and Tectonic transmembrane proteins are 
likely to mediate interactions with and modulate the function of 
membrane-targeting proteins such as RPGRIP1L and CC2D2A 
that contain C2 domains (90, 91). TCTN1, for example, forms 
a biochemical complex at the TZ with CC2D2A, other ciliary 
transmembrane proteins (TCTN2, TMEM216, and TMEM67), 
and other known ciliopathy proteins (MKS1, CEP290, and 
B9D1) (92). The role of CEP290 and the B9 domain-containing 
proteins B9D1 (MKS9) and B9D2 (MKS10) at the TZ is unde-
fined, but by analogy with the C2 domain-containing proteins, 
they are likely to mediate protein–protein interactions through 
their coiled-coil or B9 domains. One plausible model suggests 
that these proteins link TMEMs with either vesicular cargo at 
the TZ during the process of ciliogenesis, or then subsequently 
during the ciliary trafficking of cargo proteins through the TZ 
(Figure  1G). However, functional work on AHI1/jouberin, 
a ciliary TZ protein that contains WD40 and Src Homology 3 
protein interaction domains, tends to support a general role for 
TZ proteins during vesicular trafficking because AHI1/jouberin 
interacts with RAB8A (93). RAB8A is an important small GTP/
GDP-binding protein that is essential for vesicular protein traf-
ficking from the endoplasmic reticulum to the Golgi apparatus 
and plasma membrane (93). Interestingly, AHI/jouberin also 
directly interacts and sequestrates β-catenin (a downstream 
effector of canonical Wnt signaling) at the cilium (94, 95) and it 
therefore has functions that are additional and distinct to those 
of CEP290.
Several recent studies have provided mechanistic insights 
into how the disruption of selective permeability at the TZ 
results in the incorrect trafficking of proteins at the cilium, 
with a focus on the trafficking of enzymes, receptors, and other 
transmembrane proteins involved in intracellular signaling. 
Although two TMEMs, TMEM17 and TMEM231, localize to 
the ciliary TZ, other TZ proteins (CC2D2A and B9D1) are 
required for TMEM231 localization to the TZ (82). In turn, 
these functional interactions in the TZ regulated the traffick-
ing of ciliary G-protein-coupled receptors (GPCRs; soma-
tostatin and serotonin receptors SSTR3 and HTR6) into the 
ciliary membrane, and both B9D2 and TMEM231 mutations 
caused defective ciliogenesis and Shh signaling in mice (82). 
In a separate study, loss of TCTN1 did not affect ciliogenesis, 
but nevertheless caused defective ciliary localizations of the 
transmembrane signaling proteins Smoothened and PKD2/
polycystin-2, adenylyl cyclase 3 (ACIII; forming the secondary 
messenger cAMP), and ARL13B (a small Arf-family GTPase 
that localizes to the ciliary membrane) (92). Furthermore, the 
normal trafficking and localization of Smoothened at both 
the TZ and cilium is lost as a consequence of JBTS-associated 
mutations in RPGRIP1L that disrupt ciliary TZ architecture 
(89). In turn, the disruption of ciliary structure and function 
prevent Smoothened from mediating correct developmental 
Shh signaling (89). Disrupted compartmentalization could 
also prevent the correct ciliary transport of KIF7, a kinesin 
motor-protein that controls Shh signaling by regulating the 
amounts of activator and repressor isoforms of GLI transcrip-
tion factors (96, 97). GLI proteins mediate gene expression 
changes as a consequence of Shh signaling, and the regulatory 
roles of KIF7 appear to be both negative, by preventing the 
incorrect activation of GLI2 in the absence of Shh ligand, and 
positive, by preventing the processing of GLI3 into the repres-
sor isoform.
FUTURe PeRSPeCTiveS
At the present time, the molecular cause for only 60% of 
cases can be explained by mutations in the known MKS genes 
(28, 29, 71). The entire series of causative genes for MKS, 
MKS-like, and related ciliopathy phenotypes are therefore 
incomplete, but the remaining genes will be either uncommon 
or carry private mutations that are likely to be represented by 
single families. However, the widespread use of targeted clonal 
sequencing techniques such as multi-gene panels and WGS now 
allows the affordable re-investigation of molecular causes in the 
known MKS genes for individuals that have previously been 
mutation negative. These studies are likely to identify potential 
pathogenic causes that include intronic mutations, copy number 
variations, and other genic variants in promoter sequences or 
cis-regulatory elements. Although this will improve diagnostic 
rates for MKS families, these efforts are complicated by both 
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